E R I O N Q A M I R A N I
102-18 THOMAS ELGIE DR. · TORONTO, ON M4G4J5
416-797-1138
EDUCATION
· B.S. in Biology, Summa Cum Laude, 1996-2000, McMurry University, Abilene, TX
· Ph.D. in Medical Physiology, 2000-2007, Dissertation: “C-Reactive Protein Impairs Coronary Microvascular Function,” Texas A&M University Health Science Center, College Station, TX
· M.D., Honors, 2000-2007, Texas A&M University College of Medicine, College Station, TX
POSTGRADUATE TRAINING
· Orthopaedic Surgery Residency, 2007-2012, University of Toronto, Toronto, ON
· Spine Surgery Fellowship, 2012-2013, University of California San Francisco, San Francisco, CA
CERTIFICATIONS AND LICENSURE
· USMLE Step 1 (2002), Step 2 CK + CS (2006), Step 3 (2008)
· College of Physicians and Surgeons of Ontario Educational Medical License #87400 – 2007
· California Medical License #A118864 – 2011
AWARDS AND HONORS
Undergraduate
· Alpha Chi Honor Society – 1999
· Dean’s List – 1996-2000
· Kappa Mu Epsilon Mathematics Honor Society – 2000
· Outstanding Freshman, Sophomore, Junior and Senior in Biology
· Who’s Who Among Students In American Universities – 1999
Medical and Graduate School
· Alpha Omega Alpha Honor Medical Society – 2006
· American Physiological Society, Caroline tum Suden award for meritorious research – 2005
· 1st Place, Cardiovascular Research Institute poster competition, Texas A&M University – 2005
Residency
· Lawson Family Postgraduate Senior Award for Highest Academic Achievement during Residency – 2012
· Lawson Family Postgraduate Junior Award for best Orthopedic In-Training Exam score – 2010
· North American Spine Society Resident Travel Scholarship – 2010
· 2nd place, Basic Science Oral Presentation Symposium, Orthopaedic Trauma Association – 2010
GRANT SUPPORT
· Early Career Grant – Osteosynthesis and Trauma Care Foundation, Switzerland – 2009
Principal Investigator – Erion Qamirani, Supervisor – Dr. Emil Schemitsch
“Effect of multiple and delayed administrations of cell-based vascular endothelial growth factor (VEGF) gene therapy administrations on a segmental bone defect.”
TEACHING AND ACADEMIC INVOLVEMENT
· Tutored medical students in Medical Physiology, Texas A&M University College of Medicine, 2002-2005
· Lectured pre-medicine students in Cardiovascular Pathophysiology, Texas A&M University, 2004
· Elected resident member, Curriculum Committee, orthopaedic training program, University of Toronto, 2010
· Resident member, University of Toronto Spine Program, University of Toronto, 2011
INVITED ORAL PRESENTATIONS – NATIONAL SCIENTIFIC MEETINGS
· American Heart Association, Novel Coronary Regulating Mechanisms Symposium, Orlando, FL – 2003
· Experimental Biology, Young Investigator Symposium, Washington, DC – 2004
· American Heart Association, Novel Coronary Regulating Mechanisms Symposium, New Orleans, LA – 2004
· American Heart Association, Microcirculation Symposium, Dallas, TX – 2005
· Orthopaedic Trauma Association, Basic Science Symposium, Baltimore, MD – 2010
BOOK CHAPTERS
1. Malempati H, Qamirani E, Yee A. Metastatic/Myeloma Treatment – Operative Management. In: Bhandari M. Evidence-Based Orthopaedics. Wiley-Blackwell. 1075-84, 2012
2. Malempati H, Qamirani E, Yee A. Metastatic/Myeloma Treatment – Nonoperative Management. In: Bhandari M. Evidence-Based Orthopaedics. Wiley-Blackwell. 1085-95, 2012
RESEARCH PUBLICATIONS
Peer-Reviewed Papers
1. Bock BC, Vacratsis PO, Qamirani E, Gallo, KA. Cdc42-induced activation of the mixed-lineage kinase SPRK in vivo. Requirement of the Cdc42/Rac interactive binding motif and changes in phosphorylation. J. Biol. Chem. 275:14231-14241, 2000
2. Han TH, Qamirani E, Nelson AG, Hyduke DR, Chaudhuri G, Kuo L, Liao JC. Regulation of nitric oxide consumption by hypoxic red blood cells. Proc. Natl. Acad. Sci. 100:12504-12509, 2003
3. Qamirani E, Ren Y, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 25:995-1001, 2005
4. Qamirani E, Razavi H, Wu X, Davis MJ, Kuo L, Hein TW. Sodium azide dilates coronary arterioles via activation of inward rectifier K+ channels and Na+-K+ ATPase. Am. J. Physiol. Heart Circ. Physiol. 290:H1617-H1623, 2006
5. Hein TW, Qamirani E, Ren Y, Kuo L. C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: role of peroxynitrite. J Mol Cell Cardiol. 47:196-202, 2009
6. Li R, Atesok K, Nauth A, Wright D,QamiraniE, Whyne CM, Schemitsch EH. Endothelial progenitor cells for fracture healing: a microcomputed tomography and biomechanical analysis. J Orthop Trauma. 25:467-71, 2011
7. Haene R, Qamirani E, Story RA, Pinsker E, Daniels TR. Intermediate outcomes of fresh talar osteochondral allografts for treatment of large osteochondral lesions of the talus. J. Bone Joint Surg. Am. 94:1105-10, 2012
Published Abstracts
1. Qamirani E, Hein TW, Kuo L. Sodium azide dilates coronary arterioles via barium-sensitive inward rectifier potassium channels. Circulation. 108:IV-226, 2003
2. Qamirani E, Wang W, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation in coronary arterioles: roles of superoxide and vascular NADPH oxidase. FASEB J. 18:A622, 2004
3. Qamirani E, Wang W, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of coronary arterioles via p38 kinase and NADPH oxidase activation. Circulation. 110:III-73, 2004
4. Razavi H, Qamirani E, Kuo L, Hein TW. Coronary arteriolar dilation to K+ is mediated by activation of smooth muscle Kir2.1 channels and Na+/K+ ATPase. FASEB J. 19:LB55, 2005
5. Qamirani E, Wang W, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation in coronary arterioles by activating the LOX-1 receptor and NADPH oxidase. FASEB J. 19:A1265, 2005
6. Razavi H, Qamirani E, Kuo L, Hein TW. Coronary arteriolar dilation to K+: role of smooth muscle Kir2.1 channels and Na+/K+ ATPase. Circulation. 112:II-132, 2005
7. Qamirani E, Ren Y, Kuo L, Hein TW. C-reactive protein activates LOX-1 and inhibits prostacyclin-mediated dilation of coronary arterioles. Circulation. 112:II-217, 2005
8. Hein TW, Qamirani E, Shipley RD, Ren Y, Xu X, Kuo L. C-reactive protein inhibits endothelium-dependent prostacyclin synthase-mediated dilation of coronary arterioles: role of peroxynitrite. FASEB J. 21:900.12, 2007
9. Chaput C, Barber R, Dominguez D, Qamirani E, Rahm M. Injury Severity Score (ISS) Correlates with Surgical Approach in Subaxial Cervical Trauma. The Spine Journal.7:129S-130S, 2007
PROFESSIONAL ASSOCIATIONS
· American Academy Orthopaedic Surgeons
· Canadian Orthopaedic Association
· Canadian Medical Association
· Orthopaedic Trauma Association
· North American Spine Society
HOBBIES AND INTERESTS
· Soccer, basketball, mountain biking, skiing, canoeing, fishing, snorkeling